MORRISVILLE, N.C., November 6, 2023 — Premier Research announced today the addition of Elaina N. Haeuber, M.S. as Senior Vice President, Oncology. Women now lead all therapeutic specialty teams at Premier Research.
“We continue to expand and deepen our oncology team as these studies become increasingly complex and the clinical trial pipeline continues to grow,” Premier Research Chief Operating Officer Michael Arlotto, Ph.D., said. “Elaina has extensive experience in two important settings within drug development — biotech and CRO (contract research organization). She has overseen a portfolio of oncology initiatives at the executive level, covering all study phases across multiple indications, cell and gene therapy, and immuno- and targeted treatments. She is the right leader for our oncology team and will offer rich and nuanced insights to our customers in their quest to bring the latest life-saving treatments to market.”
According to GLOBOCAN (the Global Cancer Observatory), an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred worldwide in 2020 and the global cancer burden is expected to be 28.4 million cases in 2040, a 47% rise from 2020. Over the past five years, Premier Research has supported or managed 194 hematology and oncology projects, including 47 rare oncology/hematology and 36 cell and gene therapy oncology/hematology trials.
“I’m eager to join the Premier Research team and contribute my expertise to some of the most pioneering oncology assets now under development,” Senior Vice President, Oncology, Elaina Haeuber said. “I’m passionate about improving healthcare so that patients and their loved ones have access to the treatments they need. It’s a purposeful mission, not just a job, and I cannot wait to contribute to our shared success.”
Haeuber brings more than 20 years of clinical research operations and project management experience in the biopharmaceutical industry at companies including Actinium Pharmaceuticals, Syneos Health, WCG, and PPD. Programs she supported led to marketing approval in both the US and EMA. Haeuber earned a B.A. from Boston University and an M.S. from the University of Illinois at Chicago.
About Premier Research
Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping biotech, specialty pharma, and medtech innovators transform life-changing ideas and breakthrough science into new medical treatments.
Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.
Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions. Visit premier-research.com.
# # #
Contact:
Premier Research
Joe Lindroos
Vice President, Marketing
Joe.Lindroos@premier-research.com
+1 416 365 2917